Evidence map›Paper›PMID 42671397›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Tau Aggregate Imaging and Transcriptomics of Alzheimer's Disease Brain at Different Stages of Disease.

Elizabeth A English, Dorothea Böken, Matthew W Cotton, Matthew R Cheetham, Johanna S Jackson, Georg Meisl, John S H Danial, Paul M Matthews, Nurun N Fancy, David Klenerman

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elizabeth A English *Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0003-0348-9318
Dorothea Böken *Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0009-0008-8443-4469
Matthew W CottonYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0003-4078-9328
Matthew R CheethamYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0001-7412-2332
Johanna S JacksonDepartment of Brain Sciences, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-8459-0591
Georg MeislYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0002-6562-7715
John S H DanialSchool of Physics and Astronomy, University of St Andrews, St Andrews, UK.
Paul M MatthewsDepartment of Brain Sciences, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-1619-8328
Nurun N FancyDepartment of Brain Sciences, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-6481-6266
David KlenermanYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0001-7116-6954

Funding

Alzheimer's Research UKAlzheimer's SocietyEdmond J. Safra FoundationParkinson's UKRoyal SocietyUK Dementia Research InstituteUK Medical Research Council
6 · The paper itself

Abstract

Tau aggregation plays a critical role in the development and progression of Alzheimer's disease (AD). Tau aggregates of different sizes and shapes are formed, which ultimately lead to the deposition of fibrillar tangles. We used single-molecule techniques to characterize tau aggregates in the middle temporal gyrus and somatosensory cortex in post-mortem brain homogenates at different Braak stages from patients with AD. Total and phosphorylated tau aggregates increased dramatically in late Braak stages. The aggregates showed greater multi-site phosphorylation with increased Braak stage, but there was only a moderate change in the aggregate size distribution. Paired single nuclei transcriptomic analyses provided evidence for greater pro-inflammatory microglial and complement pathway activation with increasing phosphorylated tau aggregate concentration and length. Based on this correlation, we hypothesize a cascade of disease progression in which microglial inflammation induces tau aggregation in neighboring neurons that, in turn, further enhances inflammation and the spread of tau pathology to increase the concentration of small tau aggregates.

Identifiers

PMID42671397
PMCPMC13528684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.